Renal Cell Carcinoma in the Native and Allograft Kidneys of Renal Transplant Recipients

Abstract

Renal cell carcinoma is more prevalent in patients with renal transplantation than the general population, although the subtype distribution differs. Excellent survival is seen at more than 6 years after treatment.